Safety and efficacy of Hansenula-derived PEGylated-interferon alpha-2a and ribavirin combination in chronic hepatitis C Egyptian children
about
Hepatitis C Viral Infection in Children: Updated ReviewHepatitis C genotype 4: The past, present, and futureSerum Adiponectin, Vitamin D, and Alpha-Fetoprotein in Children with Chronic Hepatitis C: Can They Predict Treatment Response?Systematic review with meta-analysis: comparison between therapeutic regimens for paediatric chronic hepatitis C.Natural history and response to treatment of HCV infection among Egyptian survivors of childhood malignancy.
P2860
Safety and efficacy of Hansenula-derived PEGylated-interferon alpha-2a and ribavirin combination in chronic hepatitis C Egyptian children
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Safety and efficacy of Hansenu ...... hepatitis C Egyptian children
@en
Safety and efficacy of Hansenu ...... hepatitis C Egyptian children.
@nl
type
label
Safety and efficacy of Hansenu ...... hepatitis C Egyptian children
@en
Safety and efficacy of Hansenu ...... hepatitis C Egyptian children.
@nl
prefLabel
Safety and efficacy of Hansenu ...... hepatitis C Egyptian children
@en
Safety and efficacy of Hansenu ...... hepatitis C Egyptian children.
@nl
P2093
P2860
P356
P1476
Safety and efficacy of Hansenu ...... hepatitis C Egyptian children
@en
P2093
Ahmed M El-Hennawy
Aisha Y Abdel-Ghaffar
Aleef A Allam
Behairy E Behairy
Elham F Abdel-Aty
Hanaa A El-Araby
Hanaa El-Karaksy
Hatem El-Sebaie
Heba Helmy
Mohamed A El-Guindi
P2860
P304
P356
10.3748/WJG.V20.I16.4681
P407
P577
2014-04-01T00:00:00Z